pharmacogenetics

Researchers urged hospitals to set up processes for updating pharmacogenomic results, but it's unclear how frequently that should be done.

Although the guidelines body still doesn't back routine DPYD testing prior to starting chemo, patient advocates say it's a step in the right direction.

The companies have begun integrating Coriell's PGx services into InformedDNA's DNAimpact precision health platform for payors and employers.